SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females

被引:0
|
作者
Li, Wei [1 ]
Liu, Wei [2 ]
Wang, Xiong [3 ]
Dou, Rui [1 ]
Zhu, Zunmin [1 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Inst Hematol, Henan Key Lab Stem Cell Differentiat & Modificat,P, Zhengzhou, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Publ Hlth, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China
关键词
Tuberculosis; Polymorphism; Susceptibility; Chinese females; DRUG-INDUCED HEPATOTOXICITY; RIFAMPIN CONCENTRATIONS; RISK;
D O I
10.1007/s10528-023-10392-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate the role of SLCO1B1 polymorphisms in pulmonary tuberculosis (PTB) risk among Chinese patients. This study comprised 600 PTB patients (mean age: 37.43 & PLUSMN; 12.73 years) and 600 healthy controls (mean age: 37.39 & PLUSMN; 12.57 years) from a Chinese population. The SLCO1B1 rs2306283 and rs4149056 polymorphisms were detected using TaqMan genotyping assay. Chi-square (& chi;(2)) test was applied to calculate the Hardy-Weinberg Equilibrium (HWE) among controls. Logistic regression analysis was used to examine the odds ratio (OR) and 95% confidence interval (CI). After adjustment for age and gender, the frequency of rs4149056-C was significantly higher in PTB group (P = 0.017, OR = 1.375, 95% CI 1.058-1.786); meanwhile, rs4149056 was associated with increased PTB risk in dominant model (P = 0.015, OR = 1.424, 95% CI 1.072-1.892). The frequency and genotype of rs2306283 showed no significant difference between the two groups. In stratified analysis, rs2306283-GG showed notable susceptibility to PTB (P = 0.027, OR = 1.563, 95% CI 1.051-2.323 in recessive model) in females; rs4149056-C was also significantly higher in female PTB group (P = 0.039, OR = 1.741, 95% CI 1.028-2.948). Neither of rs2306283 and rs4149056 polymorphisms was associated with PTB risk in males. A haplotype analysis showed that patients carrying at least one SLCO1B1*15 haplotype had higher PTB risk (P = 0.004, OR = 1.527, 95% CI 1.145-2.034). SLCO1B1 polymorphisms are associated with the susceptibility to pulmonary tuberculosis in Chinese females.
引用
收藏
页码:385 / 394
页数:10
相关论文
共 50 条
  • [31] EFFECTS OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPES OF SLCO1B1 IN CHINESE ON THE PLASMA LIPID RESPONSES TO SIMVASTATIN
    Mak, V.
    Hu, M.
    Chu, T.
    Poon, E.
    Tsui, T.
    Tomlinson, B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [32] SLCO1B1 polymorphisms have effect on the lipid-lowering efficacy of pitavastatin in Chinese hyperlipemia patients
    Wen Gaiyan
    Hong Yuan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C175 - C175
  • [33] Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients
    Guo-ping Yang
    Hong Yuan
    Bin Tang
    Wei Zhang
    Lian-sheng Wang
    Zhi-jun Huang
    Dong-sheng Ou-Yang
    Gui-xiang Zhang
    Hong-hao Zhou
    Acta Pharmacologica Sinica, 2010, 31 : 382 - 386
  • [34] Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients
    Yang, Guo-ping
    Yuan, Hong
    Tang, Bin
    Zhang, Wei
    Wang, Lian-sheng
    Huang, Zhi-jun
    Ou-Yang, Dong-sheng
    Zhang, Gui-xiang
    Zhou, Hong-hao
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (03) : 382 - 386
  • [36] UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?
    de Azevedo, Laura Alencastro
    da Silveire, Themis Reverbel
    Carvalho, Clarissa Gutierrez
    de Castro, Simone Martins
    Giugliani, Roberto
    Matte, Ursula
    PEDIATRIC RESEARCH, 2012, 72 (02) : 169 - 173
  • [38] The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
    S P R Romaine
    K M Bailey
    A S Hall
    A J Balmforth
    The Pharmacogenomics Journal, 2010, 10 : 1 - 11
  • [39] Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
    Kameyama, Y
    Yamashita, K
    Kobayashi, K
    Hosokawa, M
    Chiba, K
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 513 - 522
  • [40] The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
    Romaine, S. P. R.
    Bailey, K. M.
    Hall, A. S.
    Balmforth, A. J.
    PHARMACOGENOMICS JOURNAL, 2010, 10 (01): : 1 - 11